Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Pennsylvania
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States. Strong evidence indicates that statin medications can reduce the risk of CVD and for those with CVD statins have been shown to reduce mortality. Despite this evidence, statins are under-prescribed. In this study, the investigators will test the effectiveness of nudges targeted to physicians using active choice and social comparisons feedback to increasing the rate at which statin medications are prescribed to patients eligible based on national practice guidelines.
Age
40–75
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Patient has a primary care physician at University of Pennsylvania Health System
Patient meets 2013 AHA/ACC guidelines for statin therapy but no record of a statin prescription in the electronic health record
You may not be if
Patient has an allergy or adverse reaction to statins documented in the electronic health record
Patient has glomerular filtration rate less than 30 mL/min
Physicians (and their respective patients) will be excluded if they have less than 10 patients among their entire panel that are eligible for a statin